Rhodanine derivatives: An insight into the synthetic and medicinal perspectives as antimicrobial and antiviral agents
Chemical Biology & Drug Design · 2023-03 · 101 (3) · 500-549
DOI: 10.1111/cbdd.14163 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 29.11.2022. Verfasst von Abhishek Chaurasyia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India. Hauptthemen laut MEDLINE: Rhodanine, COVID-19, Anti-Infective Agents. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 124 Literaturangaben.
Abstract (Originalsprache)
Rhodanine or 2‐Thioxothiazolidin‐4‐one is a privileged heterocyclic compound offering a wide opportunity for structural modification, lead development, and modification. It is one of the highly decorated scaffolds in the drug discovery process. Rhodanine derivatives possess a plethora of biological activities due to their ability to interact with a diverse range of protein targets, which provide tremendous opportunities to discover new drugs with different modes of action. The most common strategy for developing novel rhodanine derivatives is the introduction of structurally diverse substituents at the C‐5 or N‐3, or both positions. Since the inception of Epralestat into the market in 1992, the exploration of rhodanine‐3‐acetic acids has led to the development of novel leads against different biological targets such as MRSA, HHV‐6, Mycobacterial tuberculosis , dengue, etc. In the current pandemic era, some rhodanine compounds have been explored against SARS‐CoV‐2. In recent years, rhodanine and its derivatives have witnessed significant progress in developing new drug leads as potential antimicrobial and antiviral agents. Different synthetic methodologies and recent developments in the medicinal chemistry of rhodanine derivatives, including biological activities, their mechanistic aspects, structure–activity relationships, and in silico findings, have been compiled in the present review. This article will benefit the scientific community and offer perspectives on how these scaffolds as privileged structures might be exploited in the future for rational design and discovery of rhodanine‐based bio‐active molecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India.
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, India.
- Research Scholar, IK Gujral Punjab Technical University, Kapurthala, Punjab, India.
ORCID-Profile: Vikramdeep Monga, Gurpreet Singh
Zitieren
APA
Chaurasyia, A., Chawla, P., Monga, V., & Singh, G. (2023). Rhodanine derivatives: An insight into the synthetic and medicinal perspectives as antimicrobial and antiviral agents. Chemical Biology & Drug Design, 101(3), 500-549. https://doi.org/10.1111/cbdd.14163
Vancouver
Chaurasyia A, Chawla P, Monga V, Singh G. Rhodanine derivatives: An insight into the synthetic and medicinal perspectives as antimicrobial and antiviral agents. Chemical Biology & Drug Design. 2023;101(3):500-549. doi:10.1111/cbdd.14163
BibTeX
@article{Chaurasyia2023,
author = {Chaurasyia, Abhishek and Chawla, Pooja and Monga, Vikramdeep and Singh, Gurpreet},
title = {Rhodanine derivatives: An insight into the synthetic and medicinal perspectives as antimicrobial and antiviral agents},
journal = {Chemical Biology & Drug Design},
year = {2023},
volume = {101},
number = {3},
pages = {500--549},
doi = {10.1111/cbdd.14163}
}
EUVIMED